平衡天平:减少乳房整形的注意事项 建议对肥胖患者III类患者的建议
Jane N Ewing1, Ellen F Niu, Chris Amro
1From the Division of Plastic Surgery, Department of Surgery, University of Pennsylvania, Philadelphia, PA.
Annals of plastic surgery
|June 19, 2024
概括
减小乳房整形 (RM) 在患有III类肥胖症的患者中显示了增加的手术风险,但可以接受的结果. 建议对接受RM的严重肥胖患者进行咨询,尽管生活质量有所改善.
科学领域:
- 整形外科 整形外科 整形外科
- 肥胖医学 肥胖医学
- 手术结果研究研究.
背景情况:
- 全球肥胖率的上升给手术程序带来了挑战.
- 肥胖是影响手术结果和生活质量 (QoL) 的已知危险因素.
- 肥胖类对减少乳房整形 (RM) 结果的具体影响需要进一步定义.
研究的目的:
- 在不同肥胖类别接受RM的患者中调查手术结果和QOL.
- 为了确定身体质量指数 (BMI) 的值,RM结果变得不那么有利.
- 为了告知手术决策和患者咨询有关RM在肥胖人口.
主要方法:
- 对461名RM患者 (2016-2022) 的回顾性分析,按BMI分类为健康,超重和肥胖等级I,II和III.
- 包括BMI队列中的并发症和手术特征在内的手术结果的比较.
- 在每个BMI队列中使用手术前和手术后的BREAST-Q分数来评估QOL.
主要成果:
- 较高的BMI队列,特别是肥胖症类III,显示手术部位感染,脂肪亡,脱皮,延迟愈合和T点破裂的发生率显著增加.
- 与其他体重类别相比,III类肥胖患者经历了不利的结果.
- 虽然大多数队列显示出显著的QoL改善,但III类患者在所有QoL领域没有取得显著的收益.
结论:
- 在严重肥胖症 (III类) 中,减少乳房整形与更高的风险相关,但仍然是可以接受的.
- 接受RM的III类肥胖症患者应接受关于潜在风险的全面咨询.
- 尽管风险增加,RM仍然可以为严重肥胖的患者提供 QoL 益处,需要仔细讨论风险-益处.
相关概念视频
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:21Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...